Alkeon Capital Management - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$53,447,522
-20.7%
1,676,5220.0%0.10%
-18.6%
Q2 2023$67,362,653
-6.0%
1,676,522
-0.1%
0.12%
-25.3%
Q1 2023$71,651,368
+7.2%
1,678,018
+20.5%
0.16%
-38.8%
Q4 2022$66,863,144
+47.0%
1,392,402
+15.2%
0.26%
+75.5%
Q3 2022$45,475,000
+39.9%
1,208,822
+2.8%
0.15%
+69.0%
Q2 2022$32,505,000
-34.1%
1,176,433
+29.8%
0.09%
-12.1%
Q1 2022$49,291,000
-9.1%
906,433
-2.2%
0.10%
-1.0%
Q4 2021$54,205,000
+95.3%
926,433
+32.1%
0.10%
+112.8%
Q3 2021$27,748,000
-7.1%
701,433
-0.3%
0.05%
+6.8%
Q2 2021$29,875,000
-7.3%
703,439
+34.4%
0.04%
-8.3%
Q1 2021$32,218,000
-12.5%
523,439
+0.3%
0.05%
-20.0%
Q4 2020$36,830,000
+3083.2%
522,121
+1640.4%
0.06%
+2900.0%
Q3 2020$1,157,000
+2.8%
30,0000.0%0.00%
-33.3%
Q2 2020$1,125,00030,0000.00%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 321,300$12,087,0004.99%
First Light Asset Management, LLC 598,213$22,505,0002.28%
Nantahala Capital Management 845,692$31,815,0002.06%
CHI Advisors LLC 200,229$7,533,0002.03%
Fairmount Funds Management LLC 272,498$10,251,0001.80%
Altium Capital Management LP 88,000$3,311,0001.21%
Orbimed Advisors 1,679,417$63,180,0001.17%
SPHERA FUNDS MANAGEMENT LTD. 206,819$7,781,0001.08%
Parkman Healthcare Partners LLC 99,927$3,759,0001.07%
Soleus Capital Management, L.P. 146,000$5,493,0000.75%
View complete list of KEROS THERAPEUTICS INC shareholders